Effectiveness of Podiatry Care on Onychomycosis (EPOCAON) (EPOCAON)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00938925 |
|
Recruitment Status :
Suspended
(No funds)
First Posted : July 14, 2009
Last Update Posted : December 4, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Onychomycosis occurs in more than 50% of all pathologies unguinal, affecting the health and quality of life of the patient. Although the investigators have a wide therapeutic arsenal, there is still a disparity when carrying out an effective processing.
Hypothesis/Objectives:
To analyze if the use of the podiatric technique of aggressive unguinal abrasion with micrometer sports, in combination with topical treatment with amorolfin 5% in hairspray, significantly increases the effectiveness clinically as well as mycology.
The investigators will analyze the relationship between this intervention and the quality perception of life related to the health of the nails and the foot.
The investigators will Use results for next validation study in Spanish of the questionnaire NailQoL, as well as validation and reliability of the index SCIO and cost study-effectiveness of the processing.
Method:
The investigators will design a randomized control trial. The town will be recruited, informed prior consent will be obtained from patients of 5 Spanish centers of chiropody, with sample size of 313 patients. There will be a screening of 4 weeks to select patients with onychomycosis infections (clinic and mycology both positives); later the patients will be distributed randomly in 2 groups:
- GROUP AM+AU: Will be administered aggressive unguinal abrasion, weeks 0 (baseline), 12 and 24, followed by standard treatment of amorolfin 5%, two weekly applications during 36 weeks.
- GROUP AM: Will be administered exclusively standard treatment of amorolfin 5%, according to common format. The duration will be 48 weeks.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Onychomycosis | Procedure: Nail lacquer plus aggressive debridement Procedure: Nail lacquer alone | Phase 1 |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 64 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Investigator, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Effectiveness of Supplementation With Nail Debridement in Ungual Lacquer Treatment in Podiatry Care on Onychomycosis: Pilot Study of Randomized Control Trial |
| Study Start Date : | October 2009 |
| Actual Primary Completion Date : | December 2013 |
| Estimated Study Completion Date : | March 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Nail lacquer plus aggressive debridement
Nail lacquer plus aggressive debridement: Will be applied abrasion ungual aggressive, this abrasion will be applied in the beginning of the study, week 0 (baseline), the week 12 and the week 24 and he will follow standard treatment with nail lacquer (Odenil 5%) with 2 weekly applications during 36 weeks.
|
Procedure: Nail lacquer plus aggressive debridement
Nail lacquer plus aggressive debridement: Will be applied abrasion ungual aggressive, this abrasion will be applied in the beginning of the study, week 0 (baseline), the week 12 and the week 24 and he will follow standard treatment with nail lacquer (Odenil 5%) with 2 weekly applications during 36 weeks. |
|
Experimental: nail lacqer alone
Nail lacquer alone: Will be applied exclusively standard treatment with nail lacquer during 36 weeks, according to the usual care
|
Procedure: Nail lacquer alone
Nail lacquer alone: Will be applied exclusively standard treatment with nail lacquer during 36 weeks, according to the usual care |
- (Potassium hydroxide) KOH and cultivation negative [ Time Frame: pre and post intervention and 6 and 12 months of follow up ]
- Clinical improvements of the onychomycosis, valued with SCIO (Scoring Clinical Index for Onychomycosis) [ Time Frame: total score, pre and post intervention and 6 and 12 months of follow up ]
- Quality of life perception related the onychomycosis and foot health by nailQoL and foot health state questionnaire (FHSQ) [ Time Frame: total score, pre and post intervention and 6 and 12 months of follow up ]
- Quality of life related general health by euroQol 5-D and SF-12 [ Time Frame: total score, pre and post intervention and 6 and 12 months of follow up ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- People of both sexes with ages between 18 and 75 years.
- Having affected at least the nail out of the first toe of a foot.
- Having a confirmed diagnosis of onychomycosis with positive and evidence clinic mycology (KOH and Cultivation) both positive ones.
- The infection should be caused by a fungus dermatology. Will not afford another type of infection because of the possibility of false positives for pollution exogen.
Exclusion Criteria:
- Having received in 6 previous months some local treatment or systemic for the onychomycosis.
- Having dystrophies or alterations ungulates, apart from the ones specific to the onychomycosis, that could to interfere in the interpretation of results.
- Do not have skills for the application and tracking of the topical treatment with the hairspray ungual.
- Allergy to one of the ingredients of the nail lacquer
- Pregnancy or breastfeeding situation acquaintances at the time of recruitment.
- Use of some abrasive or cosmetic product (ej: nail paint) on the treated nail during the tracking of the study.
- Receiving some type of attendance podology or of Pedicure out of the own ones included in the study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00938925
| Spain | |
| School Health Sciences, University of Malaga | |
| Malaga, Málaga, Spain, 29009 | |
| Antonio Cuesta-vargas | |
| Malaga, Spain, 29009 | |
| Health Science School , University of Malaga | |
| Malaga, Spain, 29009 | |
| Principal Investigator: | Irene Garcia-Paya, DPM, MSc | University of Malaga | |
| Principal Investigator: | Jose A Sanchez-Castillo, DPM, MSc | University of Malaga | |
| Study Director: | Antonio I Cuesta-Vargas, PhD | University of Malaga |
Additional Information:
| Responsible Party: | Dr. Antonio I Cuesta-Vargas, PhD, University of Malaga |
| ClinicalTrials.gov Identifier: | NCT00938925 History of Changes |
| Other Study ID Numbers: |
03-2009 |
| First Posted: | July 14, 2009 Key Record Dates |
| Last Update Posted: | December 4, 2014 |
| Last Verified: | March 2010 |
Keywords provided by Dr. Antonio I Cuesta-Vargas, University of Malaga:
|
aggressive debridement nail lacquer onychomycosis |
podiatry chiropody podiatry care |
Additional relevant MeSH terms:
|
Onychomycosis Tinea Dermatomycoses Skin Diseases, Infectious |
Infection Mycoses Nail Diseases Skin Diseases |